Modified Anaphylaxis Clinical Criteria Developed for Young Children

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 22, 2024 -- Newly developed modified anaphylaxis clinical criteria can improve identification of anaphylaxis among young children, according to a study published online May 20 in the Journal of Allergy and Clinic Immunology: In Practice.

Anna Handorf, M.D., from Mass General for Children in Boston, and colleagues examined age-specific signs and symptoms that more accurately identify anaphylaxis in young children in order to develop modified criteria for "likely anaphylaxis" to compare against the widely used 2006 National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network (NIAID/FAAN) criteria. A total of 337 clinical encounters presenting to a pediatric emergency department with suspected allergic or anaphylactic reactions were reviewed. The study population comprised 33 percent infants (<12 months), 39 percent toddlers (age 12 to <36 months), and 29 percent children (≥36 months).

The researchers found that the modified criteria captured 98 percent of all patient encounters in the study, compared with 85 percent for the NIAID/FAAN criteria. Modified criteria had 22.8 and 10.3 percent improved performance among infants and toddlers, respectively, compared with NIAID/FAAN criteria.

"Utilization of modified criteria enhances identification of anaphylaxis in infants, and potentially toddlers," the authors write. "Our findings also support the need for improved training of health care professionals to recognize and manage anaphylaxis in infants and young children."

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-23 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords